The large variability in T726 and [18/19F]THK-5117 binding to tissue from Alzheimer’s disease cases is consistent with results from our previous study with [18F]flortaucipir, which demonstrate a lack of correlation between tau ligand binding to post-mortem brain tissue and pathological tau load [37]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.